Geneesmiddelenbeleid

This procedure is a motion concerning the national policy on pharmaceuticals in the Netherlands. It aims to address how medicines are managed, funded, or distributed to ensure sustainable healthcare and patient access to essential treatments. This affects the pharmaceutical industry, healthcare providers, and patients in the Netherlands by potentially altering how medicines are regulated or reimbursed.